{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T14:57:42Z","timestamp":1780066662035,"version":"3.54.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,9,20]],"date-time":"2013-09-20T00:00:00Z","timestamp":1379635200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s10120-013-0300-8","type":"journal-article","created":{"date-parts":[[2013,9,19]],"date-time":"2013-09-19T14:11:07Z","timestamp":1379599867000},"page":"200-205","source":"Crossref","is-referenced-by-count":51,"title":["Clinical application of ghrelin administration for gastric cancer patients undergoing gastrectomy"],"prefix":"10.1007","volume":"17","author":[{"given":"Shuji","family":"Takiguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Takata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitomo","family":"Yanagimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukinori","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Doki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,20]]},"reference":[{"key":"300_CR1","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1098\/rspb.2003.2341","volume":"270","author":"GE Demas","year":"2003","unstructured":"Demas GE, Drazen DL, Nelson RJ. Reductions in total body fat decrease humoral immunity. Proc Biol Sci. 2003;270:905\u201311.","journal-title":"Proc Biol Sci"},{"key":"300_CR2","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1080\/02841860152703454","volume":"40","author":"LA Marinho","year":"2001","unstructured":"Marinho LA, Rettori O, Vieira-Matos AN. Body weight loss as an indicator of breast cancer recurrence. Acta Oncol. 2001;40:832\u20137.","journal-title":"Acta Oncol"},{"key":"300_CR3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/sj.ijo.0801961","volume":"26","author":"S Tsugane","year":"2002","unstructured":"Tsugane S, Sasaki S, Tsubono Y. Under- and overweight impact on mortality among middle-aged Japanese men and women: a 10-y follow-up of JPHC study cohort I. Int J Obes Relat Metab Disord. 2002;26:529\u201337.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"300_CR4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s002689900379","volume":"22","author":"JM Bae","year":"1998","unstructured":"Bae JM, Park JW, Yang HK, Kim JP. Nutritional status of gastric cancer patients after total gastrectomy. World J Surg. 1998;22:254\u201360.","journal-title":"World J Surg"},{"key":"300_CR5","first-page":"341","volume":"91","author":"H Friess","year":"1996","unstructured":"Friess H, Bohm J, Muller MW, et al. Maldigestion after total gastrectomy is associated with pancreatic insufficiency. Am J Gastroenterol. 1996;91:341\u20137.","journal-title":"Am J Gastroenterol"},{"key":"300_CR6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1381\/096089202762552412","volume":"12","author":"J Melissas","year":"2002","unstructured":"Melissas J, Kampitakis E, Schoretsanitis G, et al. Does reduction in gastric acid secretion in bariatric surgery increase diet-induced thermogenesis? Obes Surg. 2002;12:236\u201340.","journal-title":"Obes Surg"},{"key":"300_CR7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF02483052","volume":"29","author":"S Adachi","year":"1999","unstructured":"Adachi S, Takeda T, Fukao K. Evaluation of esophageal bile reflux after total gastrectomy by gastrointestinal and hepatobiliary dual scintigraphy. Surg Today. 1999;29:301\u20136.","journal-title":"Surg Today"},{"issue":"Suppl 1","key":"300_CR8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000199542","volume":"37","author":"U Armbrecht","year":"1987","unstructured":"Armbrecht U, Lundell L, Stockbruegger RW. Nutrient malassimilation after total gastrectomy and possible intervention. Digestion. 1987;37(Suppl 1):56\u201360.","journal-title":"Digestion"},{"key":"300_CR9","first-page":"756","volume":"47","author":"H Iesato","year":"2000","unstructured":"Iesato H, Ohya T, Ohwada S, et al. Jejunal pouch interposition with an antiperistaltic conduit as a pyloric ring substitute after standard distal gastrectomy: a comparison with the use of an isoperistaltic conduit. Hepatogastroenterology. 2000;47:756\u201360.","journal-title":"Hepatogastroenterology"},{"key":"300_CR10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0031-9384(02)00958-7","volume":"78","author":"C Bergh","year":"2003","unstructured":"Bergh C, Sjostedt S, Hellers G, et al. Meal size, satiety and cholecystokinin in gastrectomized humans. Physiol Behav. 2003;78:143\u20137.","journal-title":"Physiol Behav"},{"key":"300_CR11","first-page":"477","volume":"75","author":"M Braga","year":"1988","unstructured":"Braga M, Zuliani W, Foppa L, et al. Food intake and nutritional status after total gastrectomy: results of a nutritional follow-up. Br J Surg. 1988;75:477\u201380.","journal-title":"Br J Surg"},{"key":"300_CR12","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/SLA.0b013e318167748c","volume":"247","author":"M Fein","year":"2008","unstructured":"Fein M, Fuchs KH, Thalheimer A, et al. Long-term benefits of Roux-en-Y pouch reconstruction after total gastrectomy: a randomized trial. Ann Surg. 2008;247:759\u201365.","journal-title":"Ann Surg"},{"key":"300_CR13","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0899-9007(99)00123-9","volume":"15","author":"B Liedman","year":"1999","unstructured":"Liedman B. Symptoms after total gastrectomy on food intake, body composition, bone metabolism, and quality of life in gastric cancer patients\u2013is reconstruction with a reservoir worthwhile? Nutrition. 1999;15:677\u201382.","journal-title":"Nutrition"},{"key":"300_CR14","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","volume":"402","author":"M Kojima","year":"1999","unstructured":"Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656\u201360.","journal-title":"Nature"},{"key":"300_CR15","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1210\/endo.141.11.7757","volume":"141","author":"Y Date","year":"2000","unstructured":"Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology. 2000;141:4255\u201361.","journal-title":"Endocrinology"},{"key":"300_CR16","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.drudis.2007.02.009","volume":"12","author":"AF Leite-Moreira","year":"2007","unstructured":"Leite-Moreira AF, Soares JB. Physiological, pathological and potential therapeutic roles of ghrelin. Drug Discov Today. 2007;12:276\u201388.","journal-title":"Drug Discov Today"},{"key":"300_CR17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2337\/diabetes.50.2.227","volume":"50","author":"M Shintani","year":"2001","unstructured":"Shintani M, Ogawa Y, Ebihara K, et al. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y\/Y1 receptor pathway. Diabetes. 2001;50:227\u201332.","journal-title":"Diabetes"},{"key":"300_CR18","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1006\/bbrc.2000.3568","volume":"276","author":"Y Masuda","year":"2000","unstructured":"Masuda Y, Tanaka T, Inomata N, et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun. 2000;276:905\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"300_CR19","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1210\/me.2008-0432","volume":"23","author":"JS Davies","year":"2009","unstructured":"Davies JS, Kotokorpi P, Eccles SR, et al. Ghrelin induces abdominal obesity via GHS-R-dependent lipid retention. Mol Endocrinol. 2009;23:914\u201324.","journal-title":"Mol Endocrinol"},{"key":"300_CR20","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1164\/rccm.200604-511OC","volume":"176","author":"R Wu","year":"2007","unstructured":"Wu R, Dong W, Zhou M, et al. Ghrelin attenuates sepsis-induced acute lung injury and mortality in rats. Am J Respir Crit Care Med. 2007;176:805\u201313.","journal-title":"Am J Respir Crit Care Med"},{"key":"300_CR21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2008.01.017","volume":"132","author":"J Yang","year":"2008","unstructured":"Yang J, Brown MS, Liang G, et al. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell. 2008;132:387\u201396.","journal-title":"Cell"},{"key":"300_CR22","doi-asserted-by":"crossref","first-page":"6320","DOI":"10.1073\/pnas.0800708105","volume":"105","author":"JA Gutierrez","year":"2008","unstructured":"Gutierrez JA, Solenberg PJ, Perkins DR, et al. Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci USA. 2008;105:6320\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"300_CR23","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1006\/bbrc.2000.4039","volume":"279","author":"H Hosoda","year":"2000","unstructured":"Hosoda H, Kojima M, Matsuo H, Kangawa K. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun. 2000;279:909\u201313.","journal-title":"Biochem Biophys Res Commun"},{"key":"300_CR24","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1210\/jc.2003-031768","volume":"89","author":"NM Neary","year":"2004","unstructured":"Neary NM, Small CJ, Wren AM, et al. Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab. 2004;89:2832\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"300_CR25","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1210\/jcem.86.12.8111","volume":"86","author":"AM Wren","year":"2001","unstructured":"Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001;86:5992.","journal-title":"J Clin Endocrinol Metab"},{"key":"300_CR26","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1161\/01.CIR.0000149746.62908.BB","volume":"110","author":"N Nagaya","year":"2004","unstructured":"Nagaya N, Moriya J, Yasumura Y, et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation. 2004;110:3674\u20139.","journal-title":"Circulation"},{"key":"300_CR27","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1378\/chest.128.3.1187","volume":"128","author":"N Nagaya","year":"2005","unstructured":"Nagaya N, Itoh T, Murakami S, et al. Treatment of cachexia with ghrelin in patients with COPD. Chest. 2005;128:1187\u201393.","journal-title":"Chest"},{"key":"300_CR28","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/sj.bjc.6604148","volume":"98","author":"F Strasser","year":"2008","unstructured":"Strasser F, Lutz TA, Maeder MT, et al. Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia\/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study. Br J Cancer. 2008;98:300\u20138.","journal-title":"Br J Cancer"},{"key":"300_CR29","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1002\/cncr.27430","volume":"118","author":"Y Hiura","year":"2012","unstructured":"Hiura Y, Takiguchi S, Yamamoto K, et al. Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients: a prospective, randomized, placebo-controlled phase 2 study. Cancer. 2012;118:4785\u201394.","journal-title":"Cancer"},{"key":"300_CR30","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/SLA.0b013e318156f012","volume":"247","author":"SN Karamanakos","year":"2008","unstructured":"Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg. 2008;247:401\u20137.","journal-title":"Ann Surg"},{"key":"300_CR31","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/ejcn.2010.83","volume":"64","author":"TY Jeon","year":"2010","unstructured":"Jeon TY, Lee S, Kim HH, et al. Long-term changes in gut hormones, appetite and food intake 1\u00a0year after subtotal gastrectomy with normal body weight. Eur J Clin Nutr. 2010;64:826\u201331.","journal-title":"Eur J Clin Nutr"},{"key":"300_CR32","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.1210\/jc.2004-0872","volume":"89","author":"TY Jeon","year":"2004","unstructured":"Jeon TY, Lee S, Kim HH, et al. Changes in plasma ghrelin concentration immediately after gastrectomy in patients with early gastric cancer. J Clin Endocrinol Metab. 2004;89:5392\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"300_CR33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3945\/ajcn.2008.26518","volume":"89","author":"MM Kamiji","year":"2009","unstructured":"Kamiji MM, Troncon LE, Suen VM, de Oliveira RB. Gastrointestinal transit, appetite, and energy balance in gastrectomized patients. Am J Clin Nutr. 2009;89:231\u20139.","journal-title":"Am J Clin Nutr"},{"key":"300_CR34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000207507","volume":"26","author":"S Kim","year":"2009","unstructured":"Kim S, Lee JH, Heo JS, et al. Serum obestatin\/ghrelin ratio is altered in patients after distal gastrectomy. Dig Surg. 2009;26:143\u20138.","journal-title":"Dig Surg"},{"key":"300_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jss.2005.08.003","volume":"130","author":"K Takachi","year":"2006","unstructured":"Takachi K, Doki Y, Ishikawa O, et al. Postoperative ghrelin levels and delayed recovery from body weight loss after distal or total gastrectomy. J Surg Res. 2006;130:1\u20137.","journal-title":"J Surg Res"},{"key":"300_CR36","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.3748\/wjg.14.2425","volume":"14","author":"HT Wang","year":"2008","unstructured":"Wang HT, Lu QC, Wang Q, et al. Role of the duodenum in regulation of plasma ghrelin levels and body mass index after subtotal gastrectomy. World J Gastroenterol. 2008;14:2425\u20139.","journal-title":"World J Gastroenterol"},{"key":"300_CR37","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3748\/wjg.v17.i4.449","volume":"17","author":"A Zub-Pokrowiecka","year":"2011","unstructured":"Zub-Pokrowiecka A, Rembiasz K, Konturek PC, et al. Ghrelin and gastrin in advanced gastric cancer before and after gastrectomy. World J Gastroenterol. 2011;17:449\u201358.","journal-title":"World J Gastroenterol"},{"key":"300_CR38","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1381\/0960892054621125","volume":"15","author":"FB Langer","year":"2005","unstructured":"Langer FB, Reza Hoda MA, Bohdjalian A, et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg. 2005;15:1024\u20139.","journal-title":"Obes Surg"},{"key":"300_CR39","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1590\/S0102-86502012000900001","volume":"27","author":"MB Teive","year":"2012","unstructured":"Teive MB, Russi RF, Vieira DS, et al. Quantitative immunohistochemical analysis of duodenal ghrelin cells after sleeve gastrectomy in Wistar rats. Acta Cir Bras. 2012;27:595\u20139.","journal-title":"Acta Cir Bras"},{"key":"300_CR40","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.regpep.2007.07.005","volume":"146","author":"H Hosoda","year":"2008","unstructured":"Hosoda H, Kangawa K. The autonomic nervous system regulates gastric ghrelin secretion in rats. Regul Pept. 2008;146:12\u20138.","journal-title":"Regul Pept"},{"key":"300_CR41","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.surg.2005.11.015","volume":"139","author":"Y Doki","year":"2006","unstructured":"Doki Y, Takachi K, Ishikawa O, et al. Ghrelin reduction after esophageal substitution and its correlation to postoperative body weight loss in esophageal cancer patients. Surgery. 2006;139:797\u2013805.","journal-title":"Surgery"},{"key":"300_CR42","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00595-012-0342-2","volume":"43","author":"K Yamamoto","year":"2013","unstructured":"Yamamoto K, Takiguchi S, Miyata H, et al. Reduced plasma ghrelin levels on day 1 after esophagectomy: a new predictor of prolonged systemic inflammatory response syndrome. Surg Today. 2013;43:48\u201354.","journal-title":"Surg Today"},{"key":"300_CR43","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1365-2265.2006.02528.x","volume":"64","author":"S Pekic","year":"2006","unstructured":"Pekic S, Pesko P, Djurovic M, et al. Plasma ghrelin levels of gastrectomized and vagotomized patients are not affected by glucose administration. Clin Endocrinol (Oxf). 2006;64:684\u20138.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"300_CR44","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1530\/eje.0.1510447","volume":"151","author":"R Takeno","year":"2004","unstructured":"Takeno R, Okimura Y, Iguchi G, et al. Intravenous administration of ghrelin stimulates growth hormone secretion in vagotomized patients as well as normal subjects. Eur J Endocrinol. 2004;151:447\u201350.","journal-title":"Eur J Endocrinol"},{"key":"300_CR45","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1210\/jc.2004-2537","volume":"90","author":"CW Roux le","year":"2005","unstructured":"le Roux CW, Neary NM, Halsey TJ, et al. Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy. J Clin Endocrinol Metab. 2005;90:4521\u20134.","journal-title":"J Clin Endocrinol Metab"},{"key":"300_CR46","doi-asserted-by":"crossref","first-page":"11052","DOI":"10.1523\/JNEUROSCI.2606-06.2006","volume":"26","author":"M Arnold","year":"2006","unstructured":"Arnold M, Mura A, Langhans W, Geary N. Gut vagal afferents are not necessary for the eating-stimulatory effect of intraperitoneally injected ghrelin in the rat. J Neurosci. 2006;26:11052\u201360.","journal-title":"J Neurosci"},{"key":"300_CR47","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1053\/j.gastro.2009.12.058","volume":"138","author":"S Adachi","year":"2010","unstructured":"Adachi S, Takiguchi S, Okada K, et al. Effects of ghrelin administration after total gastrectomy: a prospective, randomized, placebo-controlled phase II study. Gastroenterology. 2010;138:1312\u201320.","journal-title":"Gastroenterology"},{"key":"300_CR48","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.surg.2009.11.026","volume":"148","author":"K Yamamoto","year":"2010","unstructured":"Yamamoto K, Takiguchi S, Miyata H, et al. Randomized phase II study of clinical effects of ghrelin after esophagectomy with gastric tube reconstruction. Surgery. 2010;148:31\u20138.","journal-title":"Surgery"},{"key":"300_CR49","author":"S Takiguchi","year":"2012","unstructured":"Takiguchi S, Hiura Y, Takahashi T, et al. Effect of rikkunshito, a Japanese herbal medicine, on gastrointestinal symptoms and ghrelin levels in gastric cancer patients after gastrectomy. Gastric Cancer. 2012;. doi: 10.1007\/s10120-012-0164-3 (Epub 2012\/08\/17 PubMed PMID: 22895614).","journal-title":"Gastric Cancer"},{"key":"300_CR50","doi-asserted-by":"crossref","first-page":"8295","DOI":"10.1158\/1078-0432.CCR-05-0443","volume":"11","author":"AH Yeh","year":"2005","unstructured":"Yeh AH, Jeffery PL, Duncan RP, et al. Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogen-activated protein kinase in prostate cancer. Clin Cancer Res. 2005;11:8295\u2013303.","journal-title":"Clin Cancer Res"},{"key":"300_CR51","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.bbrc.2003.08.024","volume":"309","author":"MS Duxbury","year":"2003","unstructured":"Duxbury MS, Waseem T, Ito H, et al. Ghrelin promotes pancreatic adenocarcinoma cellular proliferation and invasiveness. Biochem Biophys Res Commun. 2003;309:464\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"300_CR52","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/BF03347371","volume":"29","author":"P Cassoni","year":"2006","unstructured":"Cassoni P, Allia E, Marrocco T, et al. Ghrelin and cortistatin in lung cancer: expression of peptides and related receptors in human primary tumors and in vitro effect on the H345 small cell carcinoma cell line. J Endocrinol Invest. 2006;29:781\u201390.","journal-title":"J Endocrinol Invest"},{"key":"300_CR53","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1677\/erc.1.00984","volume":"12","author":"PL Jeffery","year":"2005","unstructured":"Jeffery PL, Murray RE, Yeh AH, et al. Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines. Endocr Relat Cancer. 2005;12:839\u201350.","journal-title":"Endocr Relat Cancer"},{"key":"300_CR54","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/jcp.2006.038356","volume":"60","author":"M Mottershead","year":"2007","unstructured":"Mottershead M, Karteris E, Barclay JY, et al. Immunohistochemical and quantitative mRNA assessment of ghrelin expression in gastric and oesophageal adenocarcinoma. J Clin Pathol. 2007;60:405\u20139.","journal-title":"J Clin Pathol"},{"key":"300_CR55","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2012-4247","volume":"98","author":"MC Garin","year":"2013","unstructured":"Garin MC, Burns CM, Kaul S, Cappola AR. The human experience with ghrelin administration. J Clin Endocrinol Metab. 2013;98:1826\u201337.","journal-title":"J Clin Endocrinol Metab"},{"key":"300_CR56","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/jnci\/djr194","volume":"103","author":"G Murphy","year":"2011","unstructured":"Murphy G, Kamangar F, Dawsey SM, et al. The relationship between serum ghrelin and the risk of gastric and esophagogastric junctional adenocarcinomas. J Natl Cancer Inst. 2011;103:1123\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"300_CR57","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1136\/gutjnl-2011-300653","volume":"61","author":"G Murphy","year":"2012","unstructured":"Murphy G, Kamangar F, Albanes D, et al. Serum ghrelin is inversely associated with risk of subsequent oesophageal squamous cell carcinoma. Gut. 2012;61:1533\u20137.","journal-title":"Gut"},{"key":"300_CR58","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1210\/en.2003-1596","volume":"145","author":"HY Chen","year":"2004","unstructured":"Chen HY, Trumbauer ME, Chen AS, Weingarth DT, Adams JR, Frazier EG, et al. Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology. 2004;145:2607\u201312.","journal-title":"Endocrinology"},{"key":"300_CR59","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.2337\/diabetes.50.11.2438","volume":"50","author":"J Kamegai","year":"2001","unstructured":"Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, Wakabayashi I. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. Diabetes. 2001;50:2438\u201343.","journal-title":"Diabetes"},{"key":"300_CR60","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1210\/er.2006-0052","volume":"28","author":"J Gibney","year":"2007","unstructured":"Gibney J, Healy ML, Sonksen PH. The growth hormone\/insulin-like growth factor-I axis in exercise and sport. Endocr Rev. 2007;28:603\u201324.","journal-title":"Endocr Rev"},{"key":"300_CR61","doi-asserted-by":"crossref","first-page":"601","DOI":"10.7326\/0003-4819-149-9-200811040-00003","volume":"149","author":"R Nass","year":"2008","unstructured":"Nass R, Pezzoli SS, Oliveri MC, Patrie JT, Harrell FE Jr, Clasey JL, et al. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Ann Intern Med. 2008;149:601\u201311.","journal-title":"Ann Intern Med"},{"key":"300_CR62","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/bjp.2008.153","volume":"154","author":"CP Velloso","year":"2008","unstructured":"Velloso CP. Regulation of muscle mass by growth hormone and IGF-I. Br J Pharmacol. 2008;154:557\u201368.","journal-title":"Br J Pharmacol"},{"key":"300_CR63","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1161\/01.CIR.0000127956.43874.F2","volume":"109","author":"WG Li","year":"2004","unstructured":"Li WG, Gavrila D, Liu X, Wang L, Gunnlaugsson S, Stoll LL, et al. Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells. Circulation. 2004;109:2221\u20136.","journal-title":"Circulation"},{"key":"300_CR64","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.surg.2007.09.039","volume":"143","author":"T Waseem","year":"2008","unstructured":"Waseem T, Duxbury M, Ito H, Ashley SW, Robinson MK. Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways. Surgery. 2008;143:334\u201342.","journal-title":"Surgery"},{"key":"300_CR65","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.peptides.2011.03.001","volume":"32","author":"PJ Delhanty","year":"2011","unstructured":"Delhanty PJ, van der Lely AJ. Ghrelin and glucose homeostasis. Peptides. 2011;32:2309\u201318.","journal-title":"Peptides"},{"key":"300_CR66","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1210\/er.2002-0029","volume":"25","author":"AJ Lely van der","year":"2004","unstructured":"van der Lely AJ, Tschop M, Heiman ML, Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev. 2004;25:426\u201357.","journal-title":"Endocr Rev"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-013-0300-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10120-013-0300-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-013-0300-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T07:07:50Z","timestamp":1563952070000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10120-013-0300-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,20]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["300"],"URL":"https:\/\/doi.org\/10.1007\/s10120-013-0300-8","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,20]]}}}